Sigachi Industries Limited (NSE:SIGACHI)
22.35
+1.05 (4.93%)
Jun 1, 2026, 3:29 PM IST
Sigachi Industries Revenue
In the fiscal year ending March 31, 2026, Sigachi Industries had annual revenue of 4.86B INR, down -2.85%. Sigachi Industries had revenue of 1.23B in the quarter ending March 31, 2026, with 1.05% growth.
Revenue
4.86B
Revenue Growth
-2.85%
P/S Ratio
1.67
Revenue / Employee
3.23M
Employees
1,507
Market Cap
8.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 4.86B | -142.47M | -2.85% |
| Mar 31, 2025 | 5.00B | 962.25M | 23.81% |
| Mar 31, 2024 | 4.04B | 1.02B | 33.79% |
| Mar 31, 2023 | 3.02B | 517.55M | 20.68% |
| Mar 31, 2022 | 2.50B | 544.85M | 27.83% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Indoco Remedies | 18.45B |
| Nectar Lifesciences | 16.70B |
| Solara Active Pharma Sciences | 13.75B |
| Windlas Biotech | 9.04B |
| Ind-Swift Laboratories | 6.88B |
| Beta Drugs | 3.85B |
| Jagsonpal Pharmaceuticals | 2.87B |
| Sakar Healthcare | 2.54B |